The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer
Transplant Infectious Disease · 2025
DOI: 10.1111/tid.14428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Marjorie V Batista und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Infection Control, and Employee Health, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Interferon-gamma Release Tests, Neoplasms, Latent Tuberculosis, Tuberculosis. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Oxford Immunotec.
Abstract (Originalsprache)
Background
Patients with cancer are at elevated risk for tuberculosis (TB) reactivation. Diagnosis of latent TB infection and TB disease remains challenging in this patient population despite the advent of interferon‐γ release assays (IGRA).
Methods
We retrospectively reviewed medical records of all patients with cancer who had IGRA testing (QuantiFERON–TB [QFT‐TB] or T‐SPOT. TB ) at a major cancer center in the United States from June 2010 to July 2017. The results were analyzed with respect to the likelihood of latent TB infection and TB disease.
Results
A total of 1299 patients were included with 1599 tests performed: 586 QFT‐TB and 1013 T‐SPOT. TB . Forty‐nine (4%) patients were diagnosed with latent TB, and four (1%) with TB disease. T‐SPOT. TB was more likely to yield an actionable result (positive or negative) than QFT‐TB (89% vs. 65%, p < 0.001). The rate of indeterminate results for QFT‐TB was higher than the rate of invalid results for T‐SPOT. TB (35% and 10%, respectively, p < 0.001). On multivariate analysis, independent predictors of an invalid T‐SPOT. TB included prior receipt of alemtuzumab, lower hemoglobin, absolute lymphocyte count, or serum albumin ( p < 0.05 each), whereas the independent predictors of an indeterminate QFT‐TB were female gender, prior receipt of systemic corticosteroids, and lower hemoglobin, or serum albumin or higher absolute neutrophil count ( p < 0.05 each).
Conclusions
T‐SPOT. TB yielded more actionable results than QFT‐TB in patients with cancer. T‐SPOT. TB might be a better IGRA for screening for latent TB infection in patients with cancer, although a direct comparison would be needed to definitively determine this. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Infection Control, and Employee Health, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil.
- Infectious Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
- Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
- Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
ORCID-Profile: Joseph Sassine, Fareed Khawaja, Georgios Angelidakis, Ella J Ariza-Heredia
Förderung
- Oxford Immunotec
Zitieren
APA
Batista, M. V., Sassine, J., Khawaja, F., Kulkarni, P. A., Angelidakis, G., Kmeid, J., El Chaer, F., Ariza-Heredia, E. J., Graviss, E. A., Mulanovich, V. E., & Chemaly, R. F. (2025). The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer. Transplant Infectious Disease. https://doi.org/10.1111/tid.14428
Vancouver
Batista MV, Sassine J, Khawaja F, Kulkarni PA, Angelidakis G, Kmeid J, et al. The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer. Transplant Infectious Disease. 2025. doi:10.1111/tid.14428
BibTeX
@article{Batista2025,
author = {Batista, Marjorie V and Sassine, Joseph and Khawaja, Fareed and Kulkarni, Prathit A and Angelidakis, Georgios and Kmeid, Joumana and El Chaer, Firas and Ariza-Heredia, Ella J and Graviss, Edward A and Mulanovich, Victor E and Chemaly, Roy F},
title = {The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer},
journal = {Transplant Infectious Disease},
year = {2025},
doi = {10.1111/tid.14428}
}
EUVIMED